223 related articles for article (PubMed ID: 30854880)
1. Calcitonin-gene related peptide and disease activity in cluster headache.
Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
[TBL] [Abstract][Full Text] [Related]
2. PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.
Pellesi L; Chaudhry BA; Vollesen ALH; Snoer AH; Baumann K; Skov PS; Jensen RH; Ashina M
Cephalalgia; 2022 Jul; 42(8):687-695. PubMed ID: 34822741
[TBL] [Abstract][Full Text] [Related]
3. The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache.
Vollesen ALH; Snoer A; Chaudhry B; Petersen AS; Hagedorn A; Hoffmann J; Jensen RH; Ashina M
Cephalalgia; 2020 Nov; 40(13):1474-1488. PubMed ID: 32962406
[TBL] [Abstract][Full Text] [Related]
4. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.
Amin FM; Hougaard A; Schytz HW; Asghar MS; Lundholm E; Parvaiz AI; de Koning PJ; Andersen MR; Larsson HB; Fahrenkrug J; Olesen J; Ashina M
Brain; 2014 Mar; 137(Pt 3):779-94. PubMed ID: 24501094
[TBL] [Abstract][Full Text] [Related]
6. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
7. Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
Guo S; Vollesen AL; Hansen YB; Frandsen E; Andersen MR; Amin FM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):136-147. PubMed ID: 26994298
[TBL] [Abstract][Full Text] [Related]
8. S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?
Snoer AH; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Jørgensen NR; Martinussen T; Ashina M; Jensen RH
Headache; 2020 Sep; 60(8):1569-1580. PubMed ID: 32548854
[TBL] [Abstract][Full Text] [Related]
9. The role of genetics on migraine induction triggered by CGRP and PACAP38.
Guo S
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
[TBL] [Abstract][Full Text] [Related]
10. The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study.
Rasmussen NB; Deligianni C; Christensen CE; Karlsson WK; Al-Khazali HM; Van de Casteele T; Granhall C; Amin FM; Ashina M
J Headache Pain; 2023 May; 24(1):60. PubMed ID: 37231350
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.
Kruuse C; Iversen HK; Jansen-Olesen I; Edvinsson L; Olesen J
Cephalalgia; 2010 Apr; 30(4):467-74. PubMed ID: 19673898
[TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study.
Nilsson Remahl AI; Ansjön R; Lind F; Waldenlind E
Cephalalgia; 2002 Nov; 22(9):730-9. PubMed ID: 12421159
[TBL] [Abstract][Full Text] [Related]
13. PACAP38 induces migraine-like attacks in patients with migraine without aura.
Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M
Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study.
Deligianni C; Pellesi L; Chaudhry BA; Haulund Vollesen AL; Snoer AH; Hannibal J; Jensen RH; Ashina M
Front Neurol; 2023; 14():1135246. PubMed ID: 37143998
[TBL] [Abstract][Full Text] [Related]
15. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.
Goadsby PJ; Edvinsson L
Brain; 1994 Jun; 117 ( Pt 3)():427-34. PubMed ID: 7518321
[TBL] [Abstract][Full Text] [Related]
16. Effect of the H
Vollesen LH; Guo S; Andersen MR; Ashina M
Cephalalgia; 2019 Apr; 39(5):597-607. PubMed ID: 30165750
[TBL] [Abstract][Full Text] [Related]
17. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
18. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.
Fanciullacci M; Alessandri M; Figini M; Geppetti P; Michelacci S
Pain; 1995 Feb; 60(2):119-123. PubMed ID: 7540279
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
Ashina H; Newman L; Ashina S
Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
[TBL] [Abstract][Full Text] [Related]
20. Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study.
Petersen AS; Lund N; Meßlinger K; Christensen SL; Barloese M; Jørgensen NR; Kogelman L; Jensen RH
Cephalalgia; 2024 Mar; 44(3):3331024231223970. PubMed ID: 38436282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]